Lucidi Bruno 4
4 · Atea Pharmaceuticals, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
Lucidi Bruno
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-18+34,025→ 34,025 totalExercise: $23.39Exp: 2031-06-17→ Common Stock (34,025 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in twelve (12) equal monthly installments following June 18, 2021, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.